Featured Story
Featured Story
Charles River and CHDI Foundation Extend Huntington’s Disease Collaboration
Charles River and CHDI Foundation recently announced a five-year extension of their ongoing collaboration. The organizations began working together in 2005 on drug discovery and development for Huntington’s disease (HD), a genetic neurological disease that causes the progressive dysfunction of nerve cells in the brain. The extension will allow more flexible activity across the different Charles River platforms and entail greater integration into CHDI’s programs. Learn More
